Go Pro
→ Why the Treasury still prices gold at 42 dollars an ounce (From Golden Portfolio) (Ad)tc pixel Free LFVN Stock Alerts

Lifevantage (LFVN) Financials

Lifevantage logo
$6.36 -0.09 (-1.40%)
As of 08/28/2026 04:00 PM Eastern
Compare
Annual Income Statements for Lifevantage

Annual Income Statements for Lifevantage

This table shows Lifevantage's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 6.11 1.61 5.76 7.43 12 13 3.12 2.54 2.94 9.81 5.07
Consolidated Net Income / (Loss)		 6.11 1.61 5.76 7.43 12 13 3.12 2.54 2.94 9.81 5.07
Net Income / (Loss) Continuing Operations		 6.11 1.61 5.76 7.43 12 13 3.12 2.54 2.94 9.81 5.07
Total Pre-Tax Income 		8.68 2.91 9.55 9.23 15 17 4.69 4.00 4.35 12 6.07
Total Operating Income		 13 4.45 10 9.81 15 18 7.58 4.26 4.33 12 6.10
Total Gross Profit		 173 166 168 188 195 182 168 170 159 184 142
Total Revenue		 207 199 203 226 233 220 206 213 200 229 183
Operating Revenue		 207 199 203 226 233 220 206 213 200 229 183
Total Cost of Revenue		 34 33 35 38 38 38 38 43 41 45 41
Operating Cost of Revenue		 34 33 35 38 38 38 38 43 41 45 41
Total Operating Expenses		 159 162 158 178 179 164 161 166 154 171 136
Selling, General & Admin Expense		 56 65 60 70 68 61 63 71 68 69 58
Other Operating Expenses / (Income)		 103 97 98 109 112 104 97 95 86 102 77
Total Other Income / (Expense), net		 -4.73 -1.54 -0.78 -0.58 -0.81 -0.38 -2.88 -0.26 0.02 0.04 -0.03
Interest & Investment Income		 - - - - 0.00 0.00 -2.21 - - 0.43 0.16
Other Income / (Expense), net		 -1.41 -0.97 -0.32 -0.26 -0.69 -0.37 -0.67 -0.46 -0.41 -0.39 -0.20
Income Tax Expense		 2.58 1.30 3.79 1.80 3.11 4.34 1.57 1.46 1.41 2.44 0.99
Basic Earnings per Share		 $0.44 $0.12 $0.41 $0.53 $0.82 $0.92 $0.24 $0.20 $0.24 $0.80 $0.40
Weighted Average Basic Shares Outstanding		 13.73M 13.88M 13.99M 14.06M 14.11M 14.07M 12.89M 12.56M 12.46M 12.25M 12.53M
Diluted Earnings per Share		 $0.42 $0.11 $0.41 $0.50 $0.79 $0.90 $0.24 $0.20 $0.23 $0.75 $0.40
Weighted Average Diluted Shares Outstanding		 14.53M 13.40M 14.14M 14.12M 14.60M 14.27M 13.07M 12.57M 12.99M 12.99M 12.70M
Weighted Average Basic & Diluted Shares Outstanding		 14.53M 13.40M 14.14M 14.12M 14.35M 13.65M 12.55M 12.70M 12.48M 12.69M 12.53M

Quarterly Income Statements for Lifevantage

This table shows Lifevantage's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -0.66 1.66 1.31 1.83 2.55 3.47 1.96 2.16 0.28 1.36 1.28
Consolidated Net Income / (Loss)		 -0.66 1.66 1.31 1.83 2.55 3.47 1.96 2.16 0.28 1.36 1.28
Net Income / (Loss) Continuing Operations		 -0.66 1.66 1.31 1.83 2.55 3.47 1.96 2.16 0.28 1.36 1.28
Total Pre-Tax Income 		-1.11 1.92 2.71 2.58 3.09 4.18 2.40 2.24 0.47 1.66 1.70
Total Operating Income		 -1.26 1.93 2.91 2.57 3.43 4.05 2.15 2.27 0.49 1.68 1.67
Total Gross Profit		 41 38 39 38 55 47 44 38 36 35 33
Total Revenue		 52 48 49 47 68 58 55 48 49 44 42
Operating Revenue		 52 48 49 47 68 58 55 48 49 44 42
Total Cost of Revenue		 11 10 10 9.49 13 11 11 9.75 13 9.17 9.33
Operating Cost of Revenue		 11 10 10 9.49 13 11 11 9.75 13 9.17 9.33
Total Operating Expenses		 42 36 36 35 51 43 42 36 36 33 31
Selling, General & Admin Expense		 20 16 14 15 19 17 19 15 16 14 14
Other Operating Expenses / (Income)		 22 20 22 20 33 26 23 21 20 19 18
Total Other Income / (Expense), net		 0.15 -0.01 -0.20 0.01 -0.34 0.13 0.25 -0.03 -0.01 -0.02 0.03
Interest & Investment Income		 0.11 0.08 - 0.06 0.13 0.13 - 0.09 0.02 0.02 0.03
Other Income / (Expense), net		 0.04 -0.09 -0.28 -0.05 -0.47 -0.00 0.14 -0.11 -0.03 -0.05 -0.00
Income Tax Expense		 -0.46 0.26 1.41 0.75 0.54 0.71 0.44 0.09 0.20 0.29 0.42
Basic Earnings per Share		 ($0.05) $0.13 $0.11 $0.15 $0.21 $0.28 $0.16 $0.17 $0.02 $0.11 $0.10
Weighted Average Basic Shares Outstanding		 12.61M 12.42M 12.46M 12.16M 12.21M 12.35M 12.25M 12.40M 12.64M 12.63M 12.53M
Diluted Earnings per Share		 ($0.05) $0.13 $0.10 $0.14 $0.19 $0.26 $0.16 $0.17 $0.02 $0.11 $0.10
Weighted Average Diluted Shares Outstanding		 12.61M 12.99M 12.99M 12.82M 13.18M 13.30M 12.99M 12.95M 12.75M 12.66M 12.70M
Weighted Average Basic & Diluted Shares Outstanding		 12.87M 12.70M 12.48M 12.53M 12.55M 12.59M 12.69M 12.70M 12.79M 12.62M 12.53M

Annual Cash Flow Statements for Lifevantage

This table details how cash moves in and out of Lifevantage's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents		 -6.02 3.58 5.11 2.16 3.31 1.04 -2.98 1.42 -4.72 3.32 -5.28
Net Cash From Operating Activities		 6.04 6.60 13 18 18 16 7.96 6.83 12 12 10
Net Cash From Continuing Operating Activities		 6.05 6.60 13 18 18 16 7.96 6.83 12 12 10
Net Income / (Loss) Continuing Operations		 6.11 1.61 5.76 7.43 12 13 3.12 2.54 2.94 9.81 5.07
Consolidated Net Income / (Loss)		 6.11 1.61 5.76 7.43 12 13 3.12 2.54 2.94 9.81 5.07
Depreciation Expense		 1.90 1.64 1.33 1.90 2.78 3.46 3.26 3.58 3.58 3.16 2.77
Amortization Expense		 0.42 0.03 0.03 0.04 2.37 2.37 1.79 0.00 0.01 0.03 0.04
Non-Cash Adjustments To Reconcile Net Income		 5.37 3.00 3.20 5.53 4.92 2.03 3.89 4.97 4.57 7.14 6.46
Changes in Operating Assets and Liabilities, net		 -7.73 0.32 2.94 2.90 -3.29 -4.48 -4.10 -4.26 1.10 -8.25 -4.11
Net Cash From Investing Activities		 -0.56 -1.06 -4.65 -4.51 -2.68 -3.73 -1.53 -3.06 -2.25 -1.37 -7.31
Net Cash From Continuing Investing Activities		 -0.56 -1.06 -4.65 -4.51 -2.68 -3.73 -1.53 -3.06 -2.25 -1.37 -7.31
Purchase of Property, Plant & Equipment		 -0.56 -1.06 -4.65 -2.51 -2.68 -3.74 -1.53 -3.07 -2.25 -1.37 -3.57
Acquisitions		 - - - - - - - - - 0.00 -3.74
Sale of Property, Plant & Equipment		 - - - 0.00 0.00 0.01 0.00 0.01 0.00 0.00 0.00
Net Cash From Financing Activities		 -12 -1.96 -3.50 -11 -12 -11 -8.95 -2.36 -14 -7.60 -7.78
Net Cash From Continuing Financing Activities		 -12 -1.96 -3.50 -11 -12 -11 -8.95 -2.36 -14 -7.60 -7.78
Repayment of Debt		 -22 -2.00 -2.06 -4.00 -1.50 0.00 - 0.00 -0.10 0.00 -2.51
Repurchase of Common Equity		 0.00 0.00 -1.50 -4.66 -5.41 -12 -8.83 -0.82 -6.43 -3.15 -2.04
Payment of Dividends		 - - - - 0.00 0.00 -0.38 -1.59 -6.94 -2.07 -2.34
Issuance of Debt		 10 - - - - - - - - 0.00 2.50
Issuance of Common Equity		 0.26 0.04 0.06 0.70 0.73 1.90 0.51 0.25 0.27 0.28 0.23
Other Financing Activities, net		 0.27 0.00 0.00 -3.17 -6.25 -1.42 -0.25 -0.20 -1.22 -2.66 -3.62
Effect of Exchange Rate Changes		 0.20 - - - 0.09 -0.05 -0.46 0.00 -0.25 0.40 -0.43
Cash Interest Paid		 1.34 0.44 0.35 0.23 0.04 0.02 0.01 0.01 0.02 0.00 0.01
Cash Income Taxes Paid		 1.37 5.50 2.87 1.29 1.62 4.02 2.60 1.87 2.31 4.92 1.00

Quarterly Cash Flow Statements for Lifevantage

This table details how cash moves in and out of Lifevantage's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -1.07 0.05 -0.49 -2.29 7.00 0.87 -2.27 -7.11 -2.91 2.30 2.44
Net Cash From Operating Activities		 1.76 3.09 2.58 -0.58 9.20 2.23 1.03 -2.31 2.79 4.99 4.77
Net Cash From Continuing Operating Activities		 1.76 3.09 2.58 -0.58 9.20 2.23 1.03 -2.31 2.79 4.99 4.77
Net Income / (Loss) Continuing Operations		 -0.66 1.66 1.31 1.83 2.55 3.47 1.96 2.16 0.28 1.36 1.28
Consolidated Net Income / (Loss)		 -0.66 1.66 1.31 1.83 2.55 3.47 1.96 2.16 0.28 1.36 1.28
Depreciation Expense		 0.96 0.90 0.81 0.80 0.81 0.80 0.75 0.61 0.75 0.71 0.70
Amortization Expense		 -0.22 0.92 -0.91 0.36 -0.35 0.01 0.01 0.01 0.70 -0.68 0.01
Non-Cash Adjustments To Reconcile Net Income		 1.33 -1.72 2.05 0.91 2.43 1.88 1.91 1.18 4.09 0.51 0.70
Changes in Operating Assets and Liabilities, net		 0.34 1.33 -0.66 -4.48 3.76 -3.93 -3.60 -6.25 -3.02 3.09 2.08
Net Cash From Investing Activities		 -0.54 -0.29 -0.28 -0.35 -0.49 -0.33 -0.20 -0.44 -4.83 -1.01 -1.04
Net Cash From Continuing Investing Activities		 -0.54 -0.29 -0.28 -0.35 -0.49 -0.33 -0.20 -0.44 -4.83 -1.01 -1.04
Purchase of Property, Plant & Equipment		 -0.54 -0.29 -0.28 -0.35 -0.49 -0.33 -0.20 -0.44 -1.08 -1.01 -1.04
Net Cash From Financing Activities		 -2.54 -2.46 -2.74 -1.83 -1.40 -1.13 -3.24 -4.30 -0.74 -1.60 -1.15
Net Cash From Continuing Financing Activities		 -2.54 -2.46 -2.74 -1.83 -1.40 -1.13 -3.24 -4.30 -0.74 -1.60 -1.15
Repurchase of Common Equity		 -1.88 -1.93 -1.83 -1.11 - - -2.03 -0.58 0.00 -1.01 -0.46
Payment of Dividends		 -0.46 -0.45 -0.50 -0.50 -0.50 -0.50 -0.56 -0.57 -0.58 -0.57 -0.63
Other Financing Activities, net		 -0.21 -0.23 -0.31 -0.35 -0.90 -0.77 -0.65 -3.28 -0.16 -0.10 -0.07
Effect of Exchange Rate Changes		 0.26 -0.29 -0.05 0.47 -0.31 0.10 0.14 -0.07 -0.14 -0.08 -0.14
Cash Interest Paid		 0.00 0.00 0.02 0.01 -0.01 - 0.00 0.00 0.01 0.00 0.00
Cash Income Taxes Paid		 0.47 0.75 0.93 2.00 0.06 1.52 1.33 0.77 0.10 0.06 0.08

Annual Balance Sheets for Lifevantage

This table presents Lifevantage's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets		 51 45 51 55 59 79 71 66 60 72 62
Total Current Assets		 43 36 39 43 44 48 47 44 38 51 38
Cash & Equivalents		 7.88 11 17 19 22 23 20 22 17 20 15
Accounts Receivable		 1.55 1.33 2.07 2.07 2.61 2.93 3.34 1.61 2.95 3.29 2.99
Inventories, net		 25 17 14 14 14 16 16 16 15 21 16
Prepaid Expenses		 6.30 5.27 6.14 7.31 5.23 4.77 5.21 4.75 2.44 6.10 2.83
Current Deferred & Refundable Income Taxes		 2.26 0.91 0.45 1.24 0.00 1.04 1.75 0.24 0.31 0.64 1.39
Plant, Property, & Equipment, net		 3.46 3.13 6.59 7.13 7.17 11 9.50 9.09 7.81 6.21 7.31
Total Noncurrent Assets		 4.29 6.58 5.62 4.95 7.84 20 14 13 15 15 17
Goodwill		 - - - - - - - - - 0.00 0.47
Intangible Assets		 1.74 1.25 1.12 0.98 0.85 0.72 0.59 0.46 0.32 0.25 3.06
Noncurrent Deferred & Refundable Income Taxes		 1.02 4.09 3.26 2.69 2.16 1.21 1.29 2.99 4.27 5.97 5.63
Other Noncurrent Operating Assets		 1.52 1.24 1.25 1.28 4.82 18 12 9.31 10 8.64 7.35
Total Liabilities & Shareholders' Equity		 51 45 51 55 59 79 71 66 60 72 62
Total Liabilities		 40 31 29 28 26 42 39 31 34 37 29
Total Current Liabilities		 31 23 24 26 25 25 26 20 22 27 20
Accounts Payable		 8.89 4.85 3.81 5.18 3.52 6.74 7.46 3.51 5.85 4.60 5.16
Accrued Expenses		 16 16 18 19 20 15 15 15 14 21 13
Other Current Liabilities		 - - - - 1.18 2.15 2.60 1.52 1.81 1.87 1.94
Total Noncurrent Liabilities		 9.58 7.37 5.39 1.88 0.60 17 13 12 12 10 8.30
Capital Lease Obligations		 - - - - - 16 13 12 12 9.81 7.93
Other Noncurrent Operating Liabilities		 2.17 1.93 1.98 1.88 0.60 0.69 0.31 0.30 0.20 0.29 0.36
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 11 15 22 27 33 37 32 35 26 35 34
Total Preferred & Common Equity		 11 15 22 27 33 37 32 35 26 35 34
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 11 15 22 27 33 37 32 35 26 35 34
Common Stock		 119 122 125 127 126 129 131 134 137 140 139
Retained Earnings		 -109 -107 -103 -100 -93 -92 -98 -98 -109 -104 -103
Accumulated Other Comprehensive Income / (Loss)		 -0.01 -0.09 0.01 0.06 0.14 0.10 -1.12 -1.36 -1.92 -1.18 -1.87

Quarterly Balance Sheets for Lifevantage

This table presents Lifevantage's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 67 63 61 61 69 77 62 61 62
Total Current Assets		 42 39 38 39 46 54 45 39 39
Cash & Equivalents		 18 17 17 15 22 22 13 10 12
Accounts Receivable		 2.50 2.34 2.14 2.97 2.09 3.24 2.43 2.26 2.42
Inventories, net		 16 15 15 17 17 22 21 19 18
Prepaid Expenses		 5.14 3.79 2.76 3.45 4.64 6.18 3.64 4.42 3.83
Current Deferred & Refundable Income Taxes		 0.15 0.23 0.36 0.89 0.00 0.00 5.30 2.73 2.20
Plant, Property, & Equipment, net		 9.31 8.97 8.35 7.48 7.14 6.73 6.00 6.43 6.85
Total Noncurrent Assets		 15 15 15 15 16 16 11 16 16
Goodwill		 - - - - - - - 0.47 0.47
Intangible Assets		 0.42 0.39 0.36 0.29 0.26 0.22 0.25 3.32 3.19
Noncurrent Deferred & Refundable Income Taxes		 4.69 4.62 4.93 4.78 5.78 6.89 1.99 4.51 4.81
Other Noncurrent Operating Assets		 10 10 9.88 10 9.56 9.28 8.30 7.88 7.50
Total Liabilities & Shareholders' Equity		 67 63 61 61 69 77 62 61 62
Total Liabilities		 37 35 35 34 39 43 28 28 29
Total Current Liabilities		 25 23 22 22 28 33 19 19 20
Accounts Payable		 6.76 6.24 6.95 5.27 5.76 7.04 4.36 4.89 5.15
Accrued Expenses		 15 14 13 15 19 23 13 12 13
Other Current Liabilities		 1.66 1.65 1.68 1.90 1.89 1.93 1.88 1.89 1.89
Total Noncurrent Liabilities		 13 12 12 12 11 11 9.59 9.17 8.69
Capital Lease Obligations		 12 12 12 11 11 10 9.31 8.80 8.32
Other Noncurrent Operating Liabilities		 0.15 0.23 0.21 0.23 0.21 0.22 0.28 0.37 0.37
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 29 27 27 28 30 34 33 33 33
Total Preferred & Common Equity		 29 27 27 28 30 34 33 33 33
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 29 27 27 28 30 34 33 33 33
Common Stock		 135 135 136 137 138 139 138 138 139
Retained Earnings		 -104 -107 -108 -109 -106 -104 -103 -103 -104
Accumulated Other Comprehensive Income / (Loss)		 -1.66 -1.19 -1.72 -1.13 -1.81 -1.55 -1.36 -1.61 -1.73

Annual Metrics And Ratios for Lifevantage

This table displays calculated financial ratios and metrics derived from Lifevantage's official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding		 14,008,252.00 14,232,609.00 14,306,851.00 14,340,159.00 14,313,179.00 14,004,850.00 12,590,098.00 12,794,719.00 - 12,588,183.00 12,615,822.00
DEI Adjusted Shares Outstanding		 14,008,252.00 14,232,609.00 14,306,851.00 14,340,159.00 14,313,179.00 14,004,850.00 12,590,098.00 12,794,719.00 - 12,588,183.00 12,615,822.00
DEI Earnings Per Adjusted Shares Outstanding		 0.44 0.11 0.40 0.52 0.81 0.92 0.25 0.20 - 0.78 0.40
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 8.51% -3.41% 1.86% 11.20% 3.08% -5.47% -6.28% 3.41% -6.20% 14.17% -20.10%
EBITDA Growth		 -13.13% -64.00% 120.43% 1.14% 73.43% 15.79% -48.20% -38.26% 1.73% 99.79% -41.91%
EBIT Growth		 -12.63% -71.01% 187.47% -4.51% 54.73% 16.70% -59.96% -44.96% 3.13% 201.33% -50.03%
NOPAT Growth		 1.46% -73.93% 153.36% 26.82% 54.24% 8.19% -61.78% -46.31% 8.12% 234.03% -47.79%
Net Income Growth		 -14.30% -73.67% 258.27% 28.95% 55.46% 11.65% -75.80% -18.59% 15.63% 233.84% -48.27%
EPS Growth		 -16.00% -73.81% 272.73% 21.95% 58.00% 13.92% -73.33% -16.67% 15.00% 226.09% -46.67%
Operating Cash Flow Growth		 -54.35% 9.29% 100.94% 34.20% 3.02% -11.20% -51.09% -14.21% 78.63% -2.62% -13.78%
Free Cash Flow Firm Growth		 -48.05% -35.06% 46.22% 45.54% 24.14% -149.27% 290.43% -74.81% 157.42% -3.08% -57.21%
Invested Capital Growth		 33.88% -13.68% 1.88% -8.20% 13.09% 166.87% -17.48% 0.53% -15.05% 16.00% 9.69%
Revenue Q/Q Growth		 3.89% -1.18% 1.70% 0.95% 1.39% -2.04% -1.82% 1.56% -2.57% 2.78% -6.52%
EBITDA Q/Q Growth		 9.87% -28.51% 38.19% 16.20% 7.63% -0.26% -28.89% -6.27% -14.90% 3.56% -7.16%
EBIT Q/Q Growth		 13.96% -36.53% 46.54% 17.72% 3.86% 2.31% -43.26% 48.30% 4.93% -2.87% -9.53%
NOPAT Q/Q Growth		 40.56% -55.75% 82.03% 11.04% -1.26% 9.00% -48.74% 145.65% -15.25% 3.45% -8.84%
Net Income Q/Q Growth		 51.40% -59.40% 101.93% 14.05% -0.71% 9.17% -66.96% 401.66% -18.37% 7.15% -11.82%
EPS Q/Q Growth		 40.00% -60.71% 105.00% 11.11% 0.00% 11.11% -65.71% 433.33% -17.86% 8.70% -13.04%
Operating Cash Flow Q/Q Growth		 -42.28% 47.95% 35.81% 9.30% 14.82% -5.65% -41.28% 16.82% -8.83% -11.53% 57.36%
Free Cash Flow Firm Q/Q Growth		 -30.76% 29.81% 27.45% 14.63% 7.27% -150.76% 383.26% -88.28% 137.26% -26.33% 270.21%
Invested Capital Q/Q Growth		 18.83% -16.76% -5.37% -8.75% -14.18% 105.04% -12.28% 0.00% -1.59% 10.40% -8.83%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 83.57% 83.23% 82.85% 83.19% 83.70% 82.66% 81.54% 79.67% 79.30% 80.37% 77.56%
EBITDA Margin		 6.93% 2.58% 5.59% 5.09% 8.56% 10.48% 5.79% 3.46% 3.75% 6.56% 4.77%
Operating Margin		 6.49% 2.23% 5.08% 4.34% 6.64% 8.00% 3.67% 2.00% 2.16% 5.34% 3.34%
EBIT Margin		 5.81% 1.74% 4.92% 4.23% 6.35% 7.83% 3.35% 1.78% 1.96% 5.17% 3.23%
Profit (Net Income) Margin		 2.96% 0.81% 2.84% 3.29% 4.96% 5.86% 1.51% 1.19% 1.47% 4.29% 2.78%
Tax Burden Percent		 70.31% 55.26% 60.34% 80.49% 78.77% 74.83% 66.51% 63.52% 67.52% 80.09% 83.61%
Interest Burden Percent		 72.34% 83.62% 95.44% 96.62% 99.19% 99.90% 67.93% 105.21% 110.97% 103.65% 102.78%
Effective Tax Rate		 29.69% 44.74% 39.66% 19.51% 21.23% 25.17% 33.49% 36.48% 32.48% 19.91% 16.39%
Return on Invested Capital (ROIC)		 88.69% 21.68% 58.72% 76.93% 116.33% 64.64% 18.61% 11.02% 12.85% 43.27% 20.06%
ROIC Less NNEP Spread (ROIC-NNEP)		 -2.49% 89.93% 64.85% 80.21% 119.54% 66.60% 45.67% 12.96% 12.69% 42.81% 20.39%
Return on Net Nonoperating Assets (RNNOA)		 -1.30% -8.90% -27.13% -46.70% -78.13% -27.83% -9.48% -3.34% -3.17% -10.93% -5.19%
Return on Equity (ROE)		 87.39% 12.77% 31.59% 30.23% 38.21% 36.81% 9.13% 7.68% 9.69% 32.34% 14.87%
Cash Return on Invested Capital (CROIC)		 59.72% 36.36% 56.85% 85.48% 104.05% -26.33% 37.76% 10.49% 29.13% 28.46% 10.81%
Operating Return on Assets (OROA)		 26.49% 7.24% 20.76% 17.95% 25.90% 25.07% 9.24% 5.56% 6.20% 17.86% 8.80%
Return on Assets (ROA)		 13.47% 3.35% 11.95% 13.96% 20.23% 18.74% 4.18% 3.71% 4.65% 14.83% 7.57%
Return on Common Equity (ROCE)		 87.39% 12.77% 31.59% 30.23% 38.21% 36.81% 9.13% 7.68% 9.69% 32.34% 14.87%
Return on Equity Simple (ROE_SIMPLE)		 57.34% 11.07% 26.25% 27.31% 34.73% 35.03% 9.90% 7.33% 11.30% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 9.43 2.46 6.23 7.90 12 13 5.04 2.71 2.92 9.77 5.10
NOPAT Margin		 4.57% 1.23% 3.07% 3.50% 5.23% 5.99% 2.44% 1.27% 1.46% 4.28% 2.79%
Net Nonoperating Expense Percent (NNEP)		 91.18% -68.25% -6.13% -3.29% -3.21% -1.96% -27.06% -1.93% 0.16% 0.46% -0.33%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - 21.98% 12.28%
Cost of Revenue to Revenue		 16.43% 16.77% 17.15% 16.81% 16.30% 17.34% 18.46% 20.33% 20.70% 19.63% 22.44%
SG&A Expenses to Revenue		 27.15% 32.54% 29.45% 30.78% 29.16% 27.63% 30.74% 33.30% 34.21% 30.28% 32.00%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 77.08% 81.00% 77.77% 78.85% 77.06% 74.66% 77.87% 77.67% 77.13% 75.03% 74.22%
Earnings before Interest and Taxes (EBIT)		 12 3.48 10 9.55 15 17 6.91 3.80 3.92 12 5.90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 14 5.15 11 11 20 23 12 7.38 7.51 15 8.71
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 15.97 3.79 3.71 6.11 5.19 2.50 1.56 1.49 3.14 4.75 2.34
Price to Tangible Book Value (P/TBV)		 19.09 4.14 3.90 6.34 5.33 2.55 1.59 1.51 3.18 4.79 2.62
Price to Revenue (P/Rev)		 0.82 0.28 0.40 0.74 0.74 0.42 0.24 0.24 0.41 0.72 0.43
Price to Earnings (P/E)		 27.84 34.20 14.12 22.36 14.95 7.12 15.78 20.32 27.76 16.79 15.52
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.77% 3.10% 7.94% 1.26% 2.96%
Earnings Yield		 3.59% 2.92% 7.08% 4.47% 6.69% 14.04% 6.34% 4.92% 3.60% 5.95% 6.44%
Enterprise Value to Invested Capital (EV/IC)		 14.09 4.85 6.55 15.13 13.54 2.86 1.72 1.69 3.66 6.36 2.70
Enterprise Value to Revenue (EV/Rev)		 0.83 0.26 0.34 0.66 0.65 0.38 0.20 0.19 0.38 0.68 0.39
Enterprise Value to EBITDA (EV/EBITDA)		 11.98 9.89 6.17 12.95 7.56 3.67 3.53 5.63 10.18 10.28 8.23
Enterprise Value to EBIT (EV/EBIT)		 14.29 14.65 7.01 15.57 10.19 4.91 6.11 10.94 19.50 13.06 12.15
Enterprise Value to NOPAT (EV/NOPAT)		 18.19 20.74 11.25 18.83 12.36 6.43 8.38 15.37 26.14 15.79 14.06
Enterprise Value to Operating Cash Flow (EV/OCF)		 28.42 7.73 5.29 8.36 8.22 5.21 5.30 6.09 6.27 12.99 7.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 27.01 12.36 11.62 16.95 13.82 0.00 4.13 16.14 11.53 24.01 26.09
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.88 0.51 0.25 0.05 0.00 0.44 0.42 0.33 0.45 0.28 0.24
Long-Term Debt to Equity		 0.70 0.37 0.16 0.00 0.00 0.44 0.42 0.33 0.45 0.28 0.24
Financial Leverage		 0.52 -0.10 -0.42 -0.58 -0.65 -0.42 -0.21 -0.26 -0.25 -0.26 -0.25
Leverage Ratio		 6.49 3.82 2.64 2.17 1.89 1.96 2.19 2.07 2.08 2.18 1.97
Compound Leverage Factor		 4.69 3.19 2.52 2.09 1.87 1.96 1.49 2.18 2.31 2.26 2.02
Debt to Total Capital		 46.91% 33.87% 19.78% 5.07% 0.00% 30.34% 29.45% 25.03% 31.23% 22.07% 19.11%
Short-Term Debt to Total Capital		 9.97% 9.10% 7.31% 5.07% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 36.94% 24.76% 12.47% 0.00% 0.00% 30.34% 29.45% 25.03% 31.23% 22.07% 19.11%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 53.09% 66.13% 80.22% 94.93% 100.00% 69.66% 70.55% 74.97% 68.77% 77.93% 80.89%
Debt to EBITDA		 0.66 1.44 0.48 0.13 0.00 0.69 1.10 1.57 1.57 0.65 0.91
Net Debt to EBITDA		 0.11 -0.78 -0.99 -1.51 0.00 -0.31 -0.59 -1.36 -0.68 -0.69 -0.80
Long-Term Debt to EBITDA		 0.52 1.06 0.30 0.00 0.00 0.69 1.10 1.57 1.57 0.65 0.91
Debt to NOPAT		 1.00 3.03 0.87 0.18 0.00 1.22 2.61 4.28 4.03 1.00 1.56
Net Debt to NOPAT		 0.16 -1.63 -1.80 -2.20 0.00 -0.54 -1.40 -3.71 -1.74 -1.06 -1.37
Long-Term Debt to NOPAT		 0.79 2.21 0.55 0.00 0.00 1.22 2.61 4.28 4.03 1.00 1.56
Altman Z-Score		 4.68 2.75 3.83 6.05 6.99 3.54 2.41 2.77 2.74 4.73 2.93
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.41 1.52 1.64 1.65 1.75 1.91 1.83 2.26 1.69 1.87 1.89
Quick Ratio		 0.31 0.55 0.79 0.80 0.99 1.04 0.91 1.18 0.89 0.86 0.89
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 6.35 4.12 6.03 8.78 11 -5.37 10 2.58 6.63 6.42 2.75
Operating Cash Flow to CapEx		 1,074.02% 625.31% 285.14% 709.86% 683.55% 435.81% 520.20% 223.21% 543.30% 868.91% 286.78%
Free Cash Flow to Firm to Interest Expense		 1.91 7.24 13.23 27.17 90.80 -315.79 1,022.32 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 1.82 11.57 29.07 55.07 152.72 957.24 795.90 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 1.65 9.72 18.88 47.32 130.38 737.59 642.90 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 4.56 4.15 4.22 4.25 4.08 3.20 2.76 3.12 3.17 3.46 2.72
Accounts Receivable Turnover		 159.92 138.25 119.50 109.34 99.62 79.56 65.90 86.22 87.77 73.21 58.11
Inventory Turnover		 1.97 1.61 2.31 2.77 2.75 2.54 2.34 2.67 2.66 2.51 2.22
Fixed Asset Turnover		 44.83 60.61 41.84 32.94 32.57 24.07 20.01 22.96 23.69 32.60 27.02
Accounts Payable Turnover		 5.90 4.87 8.05 8.45 8.73 7.44 5.36 7.91 8.86 8.58 8.40
Days Sales Outstanding (DSO)		 2.28 2.64 3.05 3.34 3.66 4.59 5.54 4.23 4.16 4.99 6.28
Days Inventory Outstanding (DIO)		 184.82 227.42 158.17 131.59 132.88 143.53 156.25 136.90 137.09 145.32 164.07
Days Payable Outstanding (DPO)		 61.88 74.96 45.37 43.22 41.83 49.06 68.05 46.13 41.21 42.52 43.45
Cash Conversion Cycle (CCC)		 125.23 155.11 115.85 91.71 94.71 99.06 93.74 95.00 100.03 107.78 126.90
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 12 11 11 9.83 11 30 24 25 21 24 27
Invested Capital Turnover		 19.42 17.59 19.16 22.01 22.24 10.80 7.62 8.69 8.80 10.12 7.18
Increase / (Decrease) in Invested Capital		 3.08 -1.67 0.20 -0.88 1.29 19 -5.19 0.13 -3.70 3.35 2.35
Enterprise Value (EV)		 172 51 70 149 151 85 42 42 76 154 72
Market Capitalization		 170 55 81 166 173 92 49 52 82 165 79
Book Value per Share		 $0.76 $1.02 $1.53 $1.90 $2.32 $2.63 $2.50 $2.71 $2.05 $2.75 $2.66
Tangible Book Value per Share		 $0.64 $0.93 $1.46 $1.83 $2.26 $2.58 $2.46 $2.67 $2.02 $2.73 $2.38
Total Capital		 20 22 27 29 33 53 45 46 38 44 42
Total Debt		 9.41 7.44 5.41 1.45 0.00 16 13 12 12 9.81 7.93
Total Long-Term Debt		 7.41 5.44 3.41 0.00 0.00 16 13 12 12 9.81 7.93
Net Debt		 1.53 -4.02 -11 -17 -22 -7.14 -7.04 -10 -5.09 -10 -6.99
Capital Expenditures (CapEx)		 0.56 1.06 4.65 2.51 2.68 3.73 1.53 3.06 2.25 1.37 3.57
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 6.60 2.73 0.48 -0.38 -3.29 -0.32 1.04 3.07 -1.55 3.48 3.15
Debt-free Net Working Capital (DFNWC)		 14 14 17 18 19 23 21 25 15 24 18
Net Working Capital (NWC)		 12 12 15 17 19 23 21 25 15 24 18
Net Nonoperating Expense (NNE)		 3.33 0.85 0.47 0.47 0.63 0.29 1.92 0.17 -0.01 -0.04 0.03
Net Nonoperating Obligations (NNO)		 1.53 -4.02 -11 -17 -22 -7.14 -7.04 -10 -5.09 -10 -6.99
Total Depreciation and Amortization (D&A)		 2.31 1.67 1.36 1.94 5.15 5.83 5.05 3.58 3.59 3.19 2.81
Debt-free, Cash-free Net Working Capital to Revenue		 3.20% 1.37% 0.24% -0.17% -1.41% -0.14% 0.50% 1.44% -0.77% 1.52% 1.73%
Debt-free Net Working Capital to Revenue		 7.01% 7.11% 8.43% 8.16% 8.09% 10.38% 10.29% 11.56% 7.66% 10.36% 9.90%
Net Working Capital to Revenue		 6.04% 6.11% 7.45% 7.52% 8.09% 10.38% 10.29% 11.56% 7.66% 10.36% 9.90%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.44 $0.12 $0.41 $0.53 $0.82 $0.92 $0.24 $0.20 $0.24 $0.80 $0.40
Adjusted Weighted Average Basic Shares Outstanding		 13.73M 13.88M 13.99M 14.06M 14.11M 14.07M 12.89M 12.56M 12.46M 12.25M 12.53M
Adjusted Diluted Earnings per Share		 $0.41 $0.11 $0.41 $0.50 $0.79 $0.90 $0.24 $0.20 $0.23 $0.75 $0.40
Adjusted Weighted Average Diluted Shares Outstanding		 14.53M 14.23M 14.09M 14.12M 14.35M 13.65M 13.07M 12.57M 12.99M 12.99M 12.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 14.53M 14.23M 14.09M 14.12M 14.35M 13.65M 12.55M 12.70M 12.48M 12.69M 12.53M
Normalized Net Operating Profit after Tax (NOPAT)		 9.43 2.46 6.23 7.90 12 13 5.04 2.71 2.92 9.77 5.10
Normalized NOPAT Margin		 4.57% 1.23% 3.07% 3.50% 5.23% 5.99% 2.44% 1.27% 1.46% 4.28% 2.79%
Pre Tax Income Margin		 4.20% 1.46% 4.70% 4.08% 6.29% 7.83% 2.27% 1.87% 2.17% 5.36% 3.32%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 3.61 6.11 21.94 29.58 123.18 1,014.65 690.60 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 2.84 4.31 13.66 24.46 101.53 775.33 503.82 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 3.45 4.25 11.74 21.82 100.83 795.00 537.60 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 2.67 2.46 3.46 16.70 79.18 555.68 350.82 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 12.12% 62.44% 236.30% 21.08% 46.21%
Augmented Payout Ratio		 0.00% 0.00% 26.04% 62.66% 46.80% 92.55% 295.22% 94.80% 455.23% 53.18% 86.49%

Quarterly Metrics And Ratios for Lifevantage

This table displays calculated financial ratios and metrics derived from Lifevantage's official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 12,713,887.00 12,868,462.00 - - - 12,551,281.00 12,588,183.00 12,691,009.00 12,701,187.00 12,793,359.00 12,615,822.00
DEI Adjusted Shares Outstanding		 12,713,887.00 12,868,462.00 - - - 12,551,281.00 12,588,183.00 12,691,009.00 12,701,187.00 12,793,359.00 12,615,822.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.05 0.13 - - - 0.28 0.16 0.17 0.02 0.11 0.10
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -3.80% -10.23% -9.76% -8.08% 31.26% 21.13% 12.64% 0.74% -27.79% -25.20% -23.11%
EBITDA Growth		 -198.96% 23.19% 20.68% 104.85% 821.52% 32.79% 20.42% -24.61% -44.27% -65.74% -22.08%
EBIT Growth		 -10.21% 14.88% 7.51% 281.09% 342.54% 119.46% -13.25% -14.49% -84.69% -59.69% -27.22%
NOPAT Growth		 -2.35% 70.17% -30.01% 220.31% 420.59% 101.44% 25.42% 19.81% -89.96% -58.98% -28.42%
Net Income Growth		 38.00% 62.33% -33.62% 190.30% 488.72% 109.16% 50.11% 18.02% -89.18% -60.75% -34.71%
EPS Growth		 37.50% 62.50% -33.33% 180.00% 480.00% 100.00% 60.00% 21.43% -89.47% -57.69% -37.50%
Operating Cash Flow Growth		 81.70% -10.17% -31.38% -112.24% 423.56% -27.97% -59.95% -295.37% -69.66% 123.88% 361.03%
Free Cash Flow Firm Growth		 -174.21% -167.76% 172.87% -85.42% 163.47% 113.50% -131.13% -536.31% -310.78% -320.70% 31.15%
Invested Capital Growth		 58.91% 0.00% -15.05% 5.22% -13.26% 3.40% 16.00% 19.58% 64.81% 32.82% 9.69%
Revenue Q/Q Growth		 0.51% -6.55% 1.42% -3.51% 43.52% -13.76% -5.69% -13.70% 2.88% -10.66% -3.06%
EBITDA Q/Q Growth		 -126.41% 872.15% -18.09% 45.51% -6.99% 42.11% -37.39% -8.91% -31.24% -12.64% 42.40%
EBIT Q/Q Growth		 -284.57% 251.23% 42.76% -4.37% 17.47% 36.84% -43.57% -5.73% -78.97% 260.26% 1.90%
NOPAT Q/Q Growth		 -255.32% 289.22% -16.16% 30.00% 55.46% 18.90% -47.80% 24.18% -86.97% 385.66% -8.91%
Net Income Q/Q Growth		 -204.29% 352.90% -21.34% 39.92% 39.65% 36.08% -43.54% 10.01% -87.19% 393.48% -6.09%
EPS Q/Q Growth		 -200.00% 360.00% -23.08% 40.00% 35.71% 36.84% -38.46% 6.25% -88.24% 450.00% -9.09%
Operating Cash Flow Q/Q Growth		 -63.13% 76.04% -16.52% -122.58% 1,677.87% -75.78% -53.59% -322.92% 221.08% 78.72% -4.43%
Free Cash Flow Firm Q/Q Growth		 -319.70% -115.60% 126.08% -88.20% 856.59% -54.15% -160.14% -65.41% -362.13% 52.00% 81.24%
Invested Capital Q/Q Growth		 -5.31% -3.91% -1.59% 17.51% -21.94% 14.55% 10.40% 21.13% 7.59% -7.69% -8.83%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 78.56% 78.92% 79.52% 79.90% 80.53% 80.98% 79.92% 79.51% 74.00% 79.02% 77.97%
EBITDA Margin		 -0.92% 7.59% 5.16% 7.79% 5.05% 8.32% 5.52% 5.83% 3.90% 3.81% 5.59%
Operating Margin		 -2.44% 4.01% 5.95% 5.44% 5.06% 6.94% 3.90% 4.77% 1.00% 3.84% 3.93%
EBIT Margin		 -2.36% 3.82% 5.38% 5.34% 4.37% 6.93% 4.15% 4.53% 0.93% 3.73% 3.92%
Profit (Net Income) Margin		 -1.27% 3.44% 2.67% 3.87% 3.76% 5.94% 3.55% 4.53% 0.56% 3.12% 3.02%
Tax Burden Percent		 58.99% 86.36% 48.12% 70.83% 82.55% 83.01% 81.76% 96.16% 58.35% 82.25% 75.41%
Interest Burden Percent		 91.15% 104.12% 102.96% 102.34% 104.39% 103.24% 104.86% 104.04% 104.42% 101.47% 101.98%
Effective Tax Rate		 0.00% 13.64% 51.88% 29.17% 17.45% 16.99% 18.24% 3.84% 41.65% 17.75% 24.59%
Return on Invested Capital (ROIC)		 -20.03% 66.96% 25.17% 31.54% 42.92% 59.25% 32.25% 38.91% 4.80% 24.11% 21.30%
ROIC Less NNEP Spread (ROIC-NNEP)		 -21.86% 67.37% 26.43% 31.42% 46.44% 58.05% 29.63% 39.66% 4.94% 24.34% 21.05%
Return on Net Nonoperating Assets (RNNOA)		 8.90% -13.90% -6.59% -5.00% -12.92% -16.78% -7.56% -4.50% -0.95% -5.86% -5.36%
Return on Equity (ROE)		 -11.13% 53.06% 18.58% 26.54% 30.00% 42.47% 24.69% 34.41% 3.85% 18.26% 15.94%
Cash Return on Invested Capital (CROIC)		 -30.11% -167.51% 29.13% 12.32% 51.63% 40.36% 28.46% 19.71% -19.11% -6.32% 10.81%
Operating Return on Assets (OROA)		 -7.68% 12.82% 17.05% 16.33% 14.12% 22.24% 14.33% 16.85% 3.00% 10.46% 10.69%
Return on Assets (ROA)		 -4.13% 11.52% 8.45% 11.84% 12.17% 19.06% 12.28% 16.86% 1.83% 8.73% 8.22%
Return on Common Equity (ROCE)		 -11.13% 53.06% 18.58% 26.54% 30.00% 42.47% 24.69% 34.41% 3.85% 18.26% 15.94%
Return on Equity Simple (ROE_SIMPLE)		 10.84% 13.44% 0.00% 14.93% 24.56% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.88 1.67 1.40 1.82 2.83 3.36 1.76 2.18 0.28 1.38 1.26
NOPAT Margin		 -1.71% 3.46% 2.86% 3.86% 4.18% 5.76% 3.19% 4.59% 0.58% 3.16% 2.97%
Net Nonoperating Expense Percent (NNEP)		 1.83% -0.41% -1.26% 0.12% -3.52% 1.20% 2.62% -0.75% -0.14% -0.22% 0.25%
Return On Investment Capital (ROIC_SIMPLE)		 -2.24% 4.32% - - 6.94% 7.57% 3.95% 5.14% 0.68% 3.31% 3.03%
Cost of Revenue to Revenue		 21.44% 21.08% 20.48% 20.10% 19.47% 19.02% 20.08% 20.49% 26.00% 20.98% 22.03%
SG&A Expenses to Revenue		 38.87% 34.05% 28.65% 31.45% 27.47% 29.20% 33.89% 31.23% 32.35% 31.72% 32.74%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 81.01% 74.91% 73.57% 74.45% 75.47% 74.05% 76.03% 74.74% 73.00% 75.18% 74.04%
Earnings before Interest and Taxes (EBIT)		 -1.22 1.85 2.63 2.52 2.96 4.05 2.29 2.15 0.45 1.63 1.66
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -0.47 3.66 2.53 3.68 3.42 4.86 3.04 2.77 1.91 1.67 2.37
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 2.75 2.87 3.14 5.44 7.35 5.26 4.75 3.72 2.37 1.66 2.34
Price to Tangible Book Value (P/TBV)		 2.79 2.91 3.18 5.50 7.41 5.29 4.79 3.75 2.68 1.86 2.62
Price to Revenue (P/Rev)		 0.36 0.37 0.41 0.77 1.04 0.80 0.72 0.54 0.37 0.28 0.43
Price to Earnings (P/E)		 25.33 21.33 27.76 36.47 29.91 19.53 16.79 12.19 9.95 9.61 15.52
Dividend Yield		 8.48% 8.47% 7.94% 1.24% 0.88% 1.12% 1.26% 1.75% 2.84% 4.17% 2.96%
Earnings Yield		 3.95% 4.69% 3.60% 2.74% 3.34% 5.12% 5.95% 8.21% 10.05% 10.41% 6.44%
Enterprise Value to Invested Capital (EV/IC)		 3.16 3.35 3.66 6.01 10.89 7.59 6.36 4.07 2.43 1.75 2.70
Enterprise Value to Revenue (EV/Rev)		 0.33 0.35 0.38 0.75 0.98 0.75 0.68 0.52 0.37 0.26 0.39
Enterprise Value to EBITDA (EV/EBITDA)		 10.93 10.07 10.18 15.72 15.72 11.51 10.28 8.49 6.11 5.44 8.23
Enterprise Value to EBIT (EV/EBIT)		 19.96 19.06 19.50 25.55 20.98 13.71 13.06 10.46 8.60 7.83 12.15
Enterprise Value to NOPAT (EV/NOPAT)		 25.17 20.63 26.14 35.40 27.03 17.65 15.79 11.82 10.14 9.13 14.06
Enterprise Value to Operating Cash Flow (EV/OCF)		 5.08 5.32 6.27 21.55 14.61 12.42 12.99 11.79 20.51 7.85 7.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 11.53 50.00 19.60 19.11 24.01 22.51 0.00 0.00 26.09
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.44 0.44 0.45 0.41 0.36 0.31 0.28 0.28 0.27 0.25 0.24
Long-Term Debt to Equity		 0.44 0.44 0.45 0.41 0.36 0.31 0.28 0.28 0.27 0.25 0.24
Financial Leverage		 -0.41 -0.21 -0.25 -0.16 -0.28 -0.29 -0.26 -0.11 -0.19 -0.24 -0.25
Leverage Ratio		 2.14 2.29 2.08 2.25 2.29 2.28 2.18 2.02 2.06 2.07 1.97
Compound Leverage Factor		 1.95 2.38 2.15 2.30 2.39 2.35 2.29 2.10 2.15 2.10 2.00
Debt to Total Capital		 30.76% 30.69% 31.23% 29.28% 26.69% 23.46% 22.07% 21.92% 21.06% 19.97% 19.11%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 30.76% 30.69% 31.23% 29.28% 26.69% 23.46% 22.07% 21.92% 21.06% 19.97% 19.11%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 69.24% 69.31% 68.77% 70.72% 73.31% 76.54% 77.93% 78.08% 78.94% 80.03% 80.89%
Debt to EBITDA		 1.90 1.68 1.57 1.22 0.82 0.72 0.65 0.66 0.70 0.89 0.91
Net Debt to EBITDA		 -0.81 -0.78 -0.68 -0.33 -0.81 -0.83 -0.69 -0.27 -0.11 -0.44 -0.80
Long-Term Debt to EBITDA		 1.90 1.68 1.57 1.22 0.82 0.72 0.65 0.66 0.70 0.89 0.91
Debt to NOPAT		 4.38 3.43 4.03 2.75 1.41 1.10 1.00 0.92 1.16 1.49 1.56
Net Debt to NOPAT		 -1.87 -1.60 -1.74 -0.75 -1.39 -1.28 -1.06 -0.37 -0.18 -0.74 -1.37
Long-Term Debt to NOPAT		 4.38 3.43 4.03 2.75 1.41 1.10 1.00 0.92 1.16 1.49 1.56
Altman Z-Score		 2.48 2.62 2.67 3.86 4.79 3.99 4.30 4.61 3.14 2.42 2.70
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.68 1.68 1.69 1.76 1.66 1.66 1.87 2.39 2.03 1.96 1.89
Quick Ratio		 0.85 0.87 0.89 0.80 0.86 0.79 0.86 0.82 0.65 0.74 0.89
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -9.08 -20 5.10 0.60 5.76 2.64 -1.59 -2.63 -12 -5.83 -1.09
Operating Cash Flow to CapEx		 323.57% 1,062.89% 928.78% -168.99% 1,869.72% 673.11% 519.60% -525.06% 257.47% 493.37% 459.69%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 3.25 3.35 3.17 3.06 3.23 3.21 3.46 3.72 3.24 2.80 2.72
Accounts Receivable Turnover		 90.00 96.23 87.77 71.64 95.95 82.73 73.21 84.88 96.73 69.02 58.11
Inventory Turnover		 2.57 2.80 2.66 2.50 2.64 2.34 2.51 2.41 2.45 2.10 2.22
Fixed Asset Turnover		 22.90 24.61 23.69 23.35 26.34 29.49 32.60 33.97 30.98 28.77 27.02
Accounts Payable Turnover		 7.12 6.11 8.86 6.77 7.15 6.26 8.58 9.37 8.39 7.01 8.40
Days Sales Outstanding (DSO)		 4.06 3.79 4.16 5.09 3.80 4.41 4.99 4.30 3.77 5.29 6.28
Days Inventory Outstanding (DIO)		 142.08 130.25 137.09 146.09 138.06 155.69 145.32 151.72 148.98 173.52 164.07
Days Payable Outstanding (DPO)		 51.26 59.74 41.21 53.89 51.05 58.27 42.52 38.94 43.53 52.07 43.45
Cash Conversion Cycle (CCC)		 94.87 74.31 100.03 97.29 90.82 101.83 107.78 117.08 109.23 126.74 126.90
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 22 21 21 25 19 22 24 29 32 29 27
Invested Capital Turnover		 11.71 19.34 8.80 8.18 10.28 10.29 10.12 8.49 8.27 7.64 7.18
Increase / (Decrease) in Invested Capital		 8.20 21 -3.70 1.22 -2.93 0.72 3.35 4.81 12 7.21 2.35
Enterprise Value (EV)		 70 71 76 148 209 167 154 120 77 51 72
Market Capitalization		 75 77 82 151 220 179 165 123 78 55 79
Book Value per Share		 $2.15 $2.08 $2.05 $2.22 $2.39 $2.71 $2.75 $2.61 $2.60 $2.61 $2.66
Tangible Book Value per Share		 $2.12 $2.05 $2.02 $2.20 $2.37 $2.69 $2.73 $2.59 $2.30 $2.32 $2.38
Total Capital		 39 39 38 39 41 44 44 42 42 42 42
Total Debt		 12 12 12 11 11 10 9.81 9.31 8.80 8.32 7.93
Total Long-Term Debt		 12 12 12 11 11 10 9.81 9.31 8.80 8.32 7.93
Net Debt		 -5.20 -5.53 -5.09 -3.13 -11 -12 -10 -3.78 -1.38 -4.16 -6.99
Capital Expenditures (CapEx)		 0.54 0.29 0.28 0.35 0.49 0.33 0.20 0.44 1.08 1.01 1.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -1.69 -2.06 -1.55 2.15 -3.35 -0.94 3.48 13 9.36 6.73 3.15
Debt-free Net Working Capital (DFNWC)		 16 15 15 17 18 22 24 26 20 19 18
Net Working Capital (NWC)		 16 15 15 17 18 22 24 26 20 19 18
Net Nonoperating Expense (NNE)		 -0.23 0.01 0.10 -0.01 0.28 -0.11 -0.20 0.03 0.01 0.02 -0.02
Net Nonoperating Obligations (NNO)		 -5.20 -5.53 -5.09 -3.13 -11 -12 -10 -3.78 -1.38 -4.16 -6.99
Total Depreciation and Amortization (D&A)		 0.75 1.82 -0.11 1.16 0.46 0.81 0.76 0.62 1.45 0.03 0.71
Debt-free, Cash-free Net Working Capital to Revenue		 -0.80% -1.00% -0.77% 1.10% -1.58% -0.42% 1.52% 5.74% 4.46% 3.45% 1.73%
Debt-free Net Working Capital to Revenue		 7.42% 7.46% 7.66% 8.54% 8.60% 9.68% 10.36% 11.46% 9.30% 9.84% 9.90%
Net Working Capital to Revenue		 7.42% 7.46% 7.66% 8.54% 8.60% 9.68% 10.36% 11.46% 9.30% 9.84% 9.90%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.05) $0.13 $0.11 $0.15 $0.21 $0.28 $0.16 $0.17 $0.02 $0.11 $0.10
Adjusted Weighted Average Basic Shares Outstanding		 12.61M 12.42M 12.46M 12.16M 12.21M 12.35M 12.25M 12.40M 12.64M 12.63M 12.53M
Adjusted Diluted Earnings per Share		 ($0.05) $0.13 $0.10 $0.14 $0.19 $0.26 $0.16 $0.17 $0.02 $0.11 $0.10
Adjusted Weighted Average Diluted Shares Outstanding		 12.61M 12.99M 12.99M 12.82M 13.18M 13.30M 12.99M 12.95M 12.75M 12.66M 12.70M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 12.87M 12.70M 12.48M 12.53M 12.55M 12.59M 12.69M 12.70M 12.79M 12.62M 12.53M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.88 1.67 2.04 1.82 2.83 3.36 1.76 2.18 0.28 1.38 1.26
Normalized NOPAT Margin		 -1.71% 3.46% 4.16% 3.86% 4.18% 5.76% 3.19% 4.59% 0.58% 3.16% 2.97%
Pre Tax Income Margin		 -2.15% 3.98% 5.54% 5.46% 4.56% 7.15% 4.35% 4.71% 0.97% 3.79% 4.00%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 230.23% 191.27% 236.30% 46.11% 26.61% 21.94% 21.08% 21.10% 28.13% 39.66% 46.21%
Augmented Payout Ratio		 348.19% 341.94% 455.23% 209.36% 93.00% 54.13% 53.18% 46.86% 61.34% 102.52% 86.49%

Financials Breakdown Chart

Key Financial Trends

Lifevantage’s recent results show a profitable but shrinking business. Revenue fell from $67.8 million in Q2 2025 and $58.4 million in Q3 2025 to $42.4 million in Q4 2026. The latest quarter also marked a sequential decline from $43.7 million in Q3 2026. Despite lower sales, the company remained profitable, reporting $1.3 million of net income, or $0.10 per diluted share, in Q4 2026.

Profitability has held up better than revenue. Q4 2026 gross profit was $33.0 million, representing a gross margin of approximately 78.0%, while operating income was $1.7 million, or about 3.9% of revenue. However, operating income remains below the $4.1 million reported in Q3 2025, when revenue was substantially higher.

Cash generation improved materially during fiscal 2026. Operating cash flow was negative $2.3 million in Q1 but turned positive in each subsequent quarter, reaching $4.8 million in Q4. Across the four fiscal 2026 quarters provided, operating cash flow totaled approximately $10.2 million, while capital expenditures totaled approximately $3.6 million. This implies positive reported free cash flow of roughly $6.7 million for the period.

  • Consistent profitability: Lifevantage reported positive net income in every quarter provided from Q3 2024 through Q4 2026, apart from the Q2 2024 loss of $656,000.
  • Strong recent operating cash flow: Operating cash flow increased from negative $2.3 million in Q1 2026 to $2.8 million in Q2, $5.0 million in Q3 and $4.8 million in Q4.
  • Positive cash generation after capital spending: Fiscal 2026 operating cash flow exceeded capital expenditures by approximately $6.7 million based on the quarters supplied.
  • Healthy short-term liquidity: At March 31, 2026, current assets of $39.3 million were nearly twice current liabilities of $20.1 million, indicating a current ratio of approximately 2.0.
  • Lower liabilities compared with early 2025: Total liabilities declined to $28.8 million at March 31, 2026, from $38.6 million at December 31, 2024, helped by lower current liabilities and reduced capital lease obligations.
  • Shareholder returns remain a cash priority: The company paid approximately $2.3 million of dividends and repurchased approximately $2.0 million of stock across fiscal 2026. These actions may support per-share value, but they also reduce cash available for reinvestment.
  • Share count has been relatively stable: Basic weighted-average shares rose from 12.2 million in Q1 2025 to 12.5 million in Q4 2026, while recent buybacks have limited more significant dilution.
  • Revenue momentum is weak: Q4 2026 revenue was approximately 23% below Q4 2025 and about 37% below Q2 2025, suggesting continued pressure on customer demand or sales activity.
  • Operating margins have compressed: Q4 2026 operating margin was approximately 3.9%, compared with about 7.0% in Q3 2025. Selling, general and administrative expense was roughly 32.7% of revenue in Q4 2026, limiting the benefit of the company’s high gross margin.
  • Inventory remains elevated: Inventory was $18.4 million at March 31, 2026, representing approximately 47% of current assets and more than seven times accounts receivable. A sustained sales slowdown could increase markdown, obsolescence or working-capital risks.

Overall, the statements present a mixed picture for LFVN investors. The company has maintained positive earnings, recently generated meaningful operating cash flow and reduced liabilities. However, the sharp decline in revenue and narrow operating margins are important warning signs. Future performance will depend on whether Lifevantage can stabilize sales while keeping operating expenses under control and converting its inventory into cash.

08/30/26 05:17 AM ETAI Generated. May Contain Errors.

Lifevantage Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Lifevantage's financial year ends in June. Their financial year 2026 ended on June 30, 2026.

Lifevantage's net income were at $5.07 million at the end of 2026, a 48.3% decrease from 2025, and a 16.9% decrease since 2016. View Lifevantage's forecast to see where analysts expect Lifevantage to go next.

Lifevantage's total operating income in 2026 was $6.10 million, based on the following breakdown:
  • Total Gross Profit: $141.61 million
  • Total Operating Expenses: $135.51 million

Over the last 10 years, Lifevantage's total revenue changed from $206.54 million in 2016 to $182.59 million in 2026, a change of -11.6%.

Lifevantage's total liabilities were at $28.52 million at the end of 2026, a 23.6% decrease from 2025, and a 29.1% decrease since 2016.

In the past 10 years, Lifevantage's cash and equivalents has ranged from $7.88 million in 2016 to $23.17 million in 2021, and is currently $14.92 million as of their latest financial filing in 2026.

Over the last 10 years, Lifevantage's book value per share changed from 0.76 in 2016 to 2.66 in 2026, a change of 250.2%.


Related Companies

Financial statements for NASDAQ:LFVN last updated on 8/27/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
MILLIONAIRE MASTERCLASS INVITE: Altucher
James Altucher says Elon Musk is preparing an unprecedented project set to surface on September 25. Altuche...
Paradigm Press | Sponsoredtc pixel
A $382 trillion migration and the position no one is talking about
Trump just signed a law requiring America's entire $382 trillion financial system to migrate to a new money ne...
Awesomely | Sponsoredtc pixel
The REAL Reason Trump is Invading Iran
For a moment… Forget about Trump’s ties to Israel. Forget about reports of Iran’s nuclear program. Be...
Banyan Hill Publishing | Sponsoredtc pixel
Leading AI Insider Issues Urgent Market Warning
A leading AI pioneer has spent $17 million on AI research and tools since 2022, building a platform now used b...
TradeSmith | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Buy this stock today
Most tech companies skip dividends entirely. This one doesn't, paying shareholders like clockwork while flying...
Chaikin Analytics | Sponsoredtc pixel
Hormuz tanker traffic collapses as the oil crisis deepens
Tanker traffic through Hormuz has plunged from 110-130 daily transits to near zero, while 17% of Qatar's LNG c...
Golden Portfolio | Sponsoredtc pixel